Literature DB >> 33552463

Cardiovascular and systemic determinants of exercise capacity in people with type 2 diabetes mellitus.

Joanna M Bilak1, Gaurav S Gulsin1, Gerry P McCann2.   

Abstract

The global burden of heart failure (HF) is on the rise owing to an increasing incidence of lifestyle related diseases, predominantly type 2 diabetes mellitus (T2D). Diabetes is an independent risk factor for cardiovascular disease, and up to 75% of those with T2D develop HF in their lifetime. T2D leads to pathological alterations within the cardiovascular system, which can progress insidiously and asymptomatically in the absence of conventional risk factors. Reduced exercise tolerance is consistently reported, even in otherwise asymptomatic individuals with T2D, and is the first sign of a failing heart. Because aggressive modification of cardiovascular risk factors does not eliminate the risk of HF in T2D, it is likely that other factors play a role in the pathogenesis of HF. Early identification of individuals at risk of HF is advantageous, as it allows for modification of the reversible risk factors and early initiation of treatment with the aim of improving clinical outcomes. In this review, cardiac and extra-cardiac contributors to reduced exercise tolerance in people with T2D are explored.
© The Author(s), 2021.

Entities:  

Keywords:  diabetic cardiomyopathy; exercise capacity; heart failure

Year:  2021        PMID: 33552463      PMCID: PMC7844448          DOI: 10.1177/2042018820980235

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN: 2042-0188            Impact factor:   3.565


  103 in total

1.  Reduced left atrial function on exercise in patients with heart failure and normal ejection fraction.

Authors:  Y T Tan; F Wenzelburger; E Lee; P Nightingale; G Heatlie; F Leyva; J E Sanderson
Journal:  Heart       Date:  2010-07       Impact factor: 5.994

Review 2.  Inflammatory mechanisms linking obesity and metabolic disease.

Authors:  Alan R Saltiel; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

3.  Atrial Fibrillation and Diabetes Mellitus: Can We Modify Stroke Risk Through Glycemic Control?

Authors:  Francis E Ugowe; Larry R Jackson; Kevin L Thomas
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-05

4.  Global Public Health Burden of Heart Failure.

Authors:  Gianluigi Savarese; Lars H Lund
Journal:  Card Fail Rev       Date:  2017-04

Review 5.  Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis.

Authors:  Labros Sidossis; Shingo Kajimura
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

Review 6.  Endothelial dysfunction in diabetes: the role of reparatory mechanisms.

Authors:  Angelo Avogaro; Mattia Albiero; Lisa Menegazzo; Saula de Kreutzenberg; Gian Paolo Fadini
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

7.  Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus.

Authors:  Louis Potier; Renata Chequer; Ronan Roussel; Kamel Mohammedi; Souad Sismail; Agnès Hartemann; Chloé Amouyal; Michel Marre; Dominique Le Guludec; Fabien Hyafil
Journal:  Cardiovasc Diabetol       Date:  2018-01-11       Impact factor: 9.951

8.  Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study.

Authors:  Timothy J Roberts; Andrew T Burns; Richard J MacIsaac; Andrew I MacIsaac; David L Prior; André La Gerche
Journal:  Cardiovasc Diabetol       Date:  2018-03-23       Impact factor: 9.951

9.  Excessive loss of skeletal muscle mass in older adults with type 2 diabetes.

Authors:  Seok Won Park; Bret H Goodpaster; Jung Sun Lee; Lewis H Kuller; Robert Boudreau; Nathalie de Rekeneire; Tamara B Harris; Stephen Kritchevsky; Frances A Tylavsky; Michael Nevitt; Yong-wook Cho; Anne B Newman
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 19.112

10.  Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants.

Authors:  Peter Hanlon; Barbara I Nicholl; Bhautesh Dinesh Jani; Duncan Lee; Ross McQueenie; Frances S Mair
Journal:  Lancet Public Health       Date:  2018-06-14
View more
  3 in total

Review 1.  Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis.

Authors:  Joanna M Bilak; Uazman Alam; Christopher A Miller; Gerry P McCann; Jayanth R Arnold; Prathap Kanagala
Journal:  Card Fail Rev       Date:  2022-07-01

2.  Endothelial HSP72 is not reduced in type 2 diabetes nor is it a key determinant of endothelial insulin sensitivity.

Authors:  Ryan J Pettit-Mee; Gavin Power; Francisco J Cabral-Amador; Francisco I Ramirez-Perez; Rogerio N Soares; Neekun Sharma; Ying Liu; Demetra D Christou; Jill A Kanaley; Luis A Martinez-Lemus; Camila Manrique-Acevedo; Jaume Padilla
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-04-26       Impact factor: 3.210

3.  Physical performance and glycemic control under SGLT-2-inhibitors in patients with type 2 diabetes and established atherosclerotic cardiovascular diseases or high cardiovascular risk (PUSH): Design of a 4-week prospective observational study.

Authors:  Devine S Frundi; Eva Kettig; Lena Luise Popp; Melanie Hoffman; Marine Dumartin; Magali Hughes; Edgar Lamy; Yvonne Joko Walburga Fru; Arjola Bano; Taulant Muka; Matthias Wilhelm
Journal:  Front Cardiovasc Med       Date:  2022-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.